Alpha-2 macroglobulin for the treatment of neuroma pain in the stump of a below-knee amputee patient.
alpha-2 macroglobulin
interventional pain medicine
neuroma
neuropathy
pain medicine
regenerative medicine
stem cell
ultrasound
ultrasound-guided
ultrasound-guided intervention
Journal
Pain management
ISSN: 1758-1877
Titre abrégé: Pain Manag
Pays: England
ID NLM: 101555934
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
medline:
22
8
2023
pubmed:
8
8
2023
entrez:
8
8
2023
Statut:
ppublish
Résumé
This case report describes the successful treatment of neuroma pain in the setting of below knee amputations using alpha-2-macroglobulin (A2M). A 34-year-old female patient presented with 9 months of stump pain despite conservative treatment. The exam revealed persistent pain through rest periods and weight-bearing status during therapy. Ultrasound showed neuroma formation with neovascularization. The patient underwent two A2M hydrodissection treatments, 2 weeks apart. The patient reported significant pain relief. Ultrasound showed decreases in neovascularization and cross-sectional area of the neuroma. The patient was able to ambulate pain-free for 2 years and reported no pain since. A2M may be a treatment for patients with neuroma pain in the setting of amputations.
Identifiants
pubmed: 37551540
doi: 10.2217/pmt-2023-0005
doi:
Substances chimiques
Pregnancy-Associated alpha 2-Macroglobulins
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM